-
-
-
-
-
-
-
Henry Schein (HSIC) Tops Q3 EPS by 10c, provides guidance
-
-
-
-
-
-
-
Henry Schein (HSIC) Misses Q2 EPS by 9c, Misses on Revenue; Offers FY25 EPS Guidance
-
-
-
-
-
-
-
Henry Schein Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
Henry Schein (HSIC) Completes Acquisition of Acentus
-
-
-
-
-
-
-
CFRA Downgrades Henry Schein (HSIC) to Sell ,'see better near-term upside in pharmaceutical distributors'
-
-
-
-
-
-
-
Henry Schein to Webcast First Quarter 2024 Conference Call on Tuesday, May 7, 2024 at 10:00 A.M. ET
-
-
-
-
-
-
-
Henry Schein Enters Extremity Segment of Orthopedic Market
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

